These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15257911)

  • 21. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.
    Desoize B; Veiler V; Pourny C; Comoe L; Jardillier JC
    Anticancer Res; 1989; 9(4):1105-9. PubMed ID: 2817792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of skeletal AP and PSA with respect to skeletal scintigram in patients with prostatic disease.
    Oremek GM; Kramer W; Seiffert UB; Jonas D
    Anticancer Res; 1997; 17(4B):3035-6. PubMed ID: 9329594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of bone gammagraphy, radiology and alkaline phosphatases in the diagnosis of bone metastases].
    Panero JF; Toledo F; Alarcó R; Allende A; Hernández Armas J; Otón C
    Rev Clin Esp; 1983 Sep; 170(5):185-8. PubMed ID: 6647939
    [No Abstract]   [Full Text] [Related]  

  • 24. [Metastatic bone disease. Strategies for imaging].
    Scutellari PN; Antinolfi G; Galeotti R; Giganti M
    Minerva Med; 2003 Apr; 94(2):77-90. PubMed ID: 12858156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osseous invasion by soft-tissue sarcoma: assessment with MR imaging.
    Elias DA; White LM; Simpson DJ; Kandel RA; Tomlinson G; Bell RS; Wunder JS
    Radiology; 2003 Oct; 229(1):145-52. PubMed ID: 14519874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
    Ebert W; Muley T; Herb KP; Schmidt-Gayk H
    Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastatic workup of patients with prostate cancer employing alkaline phosphatase and skeletal alkaline phosphatase.
    Wolff JM; Ittel TH; Borchers H; Boekels O; Jakse G
    Anticancer Res; 1999; 19(4A):2653-5. PubMed ID: 10470213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential diagnosis of atypically located single or double hot spots in whole bone scanning.
    Puig S; Staudenherz A; Steiner B; Eisenhuber E; Leitha T
    J Nucl Med; 1998 Jul; 39(7):1263-6. PubMed ID: 9669407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis of occult skeletal metastasis: alkaline phosphatase versus skeletal scintigraphy].
    Zieger M
    Med Klin Prax; 1982 May; 77(11):44-50. PubMed ID: 7099105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative evaluation of serum acid phosphatases, conventional x-ray diagnosis, bone biopsy and Sr 85-bone scanning in the diagnosis of osseous metastases in cancer of the prostate].
    Graber P; Rutishauser G; Baumann JM
    Urologe; 1971 Mar; 10(2):60-2. PubMed ID: 5577980
    [No Abstract]   [Full Text] [Related]  

  • 31. [Is routine bone scanning justified during the after-care for breast cancer?].
    Schuster R; Lenzhofer R; Pirich K; Dudzak R; Gabl F
    Dtsch Med Wochenschr; 1984 Oct; 109(43):1639-42. PubMed ID: 6149114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases.
    Morris PG; Fazio M; Farooki A; Estilo C; Mallam D; Conlin A; Patil S; Fleisher M; Cremers S; Huryn J; Hudis CA; Fornier MN
    J Oral Maxillofac Surg; 2012 Dec; 70(12):2768-75. PubMed ID: 22330331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suspected non-small cell lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection--pilot study.
    Earnest F; Ryu JH; Miller GM; Luetmer PH; Forstrom LA; Burnett OL; Rowland CM; Swensen SJ; Midthun DE
    Radiology; 1999 Apr; 211(1):137-45. PubMed ID: 10189463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic gaps in bone formation may be a novel marker to monitor the osseous metastasis of prostate cancer.
    Koizumi M; Yonese J; Fukui I; Ogata E
    J Urol; 2002 Apr; 167(4):1863-6. PubMed ID: 11912449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of serum total and bone alkaline phosphatase measurement in clinical practice.
    Romagnoli E; Minisola G; Carnevale V; Scillitani A; Frusciante V; Aliberti G; Minisola S
    Clin Chem Lab Med; 1998 Mar; 36(3):163-8. PubMed ID: 9589804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone scanning and radiography in the evaluation of patients with malignant lymphoma.
    Jánoskuti L; Szilvási I; Papp G; Róna E; Benedek S; Fekete S
    Rofo; 1988 Oct; 149(4):427-8. PubMed ID: 2845515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PINP as serum marker of metastatic spread to the bone in breast cancer patients.
    Lüftner D; Jozereau D; Schildhauer S; Geppert R; Müller C; Fiolka G; Wernecke KD; Possinger K
    Anticancer Res; 2005; 25(3A):1491-9. PubMed ID: 16033050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can sarcoidosis and metastatic bone lesions be reliably differentiated on routine MRI?
    Moore SL; Kransdorf MJ; Schweitzer ME; Murphey MD; Babb JS
    AJR Am J Roentgenol; 2012 Jun; 198(6):1387-93. PubMed ID: 22623553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum bone alkaline phosphatase and CA 549 in breast cancer with bone metastases.
    Cooper EH; Forbes MA; Hancock AK; Parker D; Laurence V
    Biomed Pharmacother; 1992; 46(1):31-6. PubMed ID: 1421033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancer.
    Aktas B; Kasimir-Bauer S; Lehmann N; Kimmig R; Tewes M
    Oncol Rep; 2013 Jul; 30(1):441-7. PubMed ID: 23604361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.